Pas HH - Search Results

1

Low-dose rituximab is effective in pemphigus.

Horváth B, Huizinga J, Pas HH, Mulder AB, Jonkman MF. Horváth B, et al. Among authors: pas hh. Br J Dermatol. 2012 Feb;166(2):405-12. doi: 10.1111/j.1365-2133.2011.10663.x. Epub 2012 Jan 9. Br J Dermatol. 2012. PMID: 21967609 Clinical Trial.

2

Bullous pemphigoid successfully controlled by tetracycline and nicotinamide.

Kolbach DN, Remme JJ, Bos WH, Jonkman MF, De Jong MC, Pas HH, van der Meer JB. Kolbach DN, et al. Among authors: pas hh. Br J Dermatol. 1995 Jul;133(1):88-90. doi: 10.1111/j.1365-2133.1995.tb02498.x. Br J Dermatol. 1995. PMID: 7669647

3

180-kD bullous pemphigoid antigen (BP180) is deficient in generalized atrophic benign epidermolysis bullosa.

Jonkman MF, de Jong MC, Heeres K, Pas HH, van der Meer JB, Owaribe K, Martinez de Velasco AM, Niessen CM, Sonnenberg A. Jonkman MF, et al. Among authors: pas hh. J Clin Invest. 1995 Mar;95(3):1345-52. doi: 10.1172/JCI117785. J Clin Invest. 1995. PMID: 7883981 Free PMC article.

4

Bullous pemphigoid: serum antibody titre and antigen specificity.

Pas HH, de Jong MC, Jonkman MF, Heeres K, Slijper-Pal IJ, van der Meer JB. Pas HH, et al. Exp Dermatol. 1995 Dec;4(6):372-6. doi: 10.1111/j.1600-0625.1995.tb00062.x. Exp Dermatol. 1995. PMID: 8608345

5

Bullous pemphigoid and epidermolysis bullosa acquisita. Differentiation by fluorescence overlay antigen mapping.

De Jong MC, Bruins S, Heeres K, Jonkman MF, Nieboer C, Boorsma DM, Pas HH, van der Meer JB. De Jong MC, et al. Among authors: pas hh. Arch Dermatol. 1996 Feb;132(2):151-7. doi: 10.1001/archderm.132.2.151. Arch Dermatol. 1996. PMID: 8629822

6

Effects of keratin 14 ablation on the clinical and cellular phenotype in a kindred with recessive epidermolysis bullosa simplex.

Jonkman MF, Heeres K, Pas HH, van Luyn MJ, Elema JD, Corden LD, Smith FJ, McLean WH, Ramaekers FC, Burton M, Scheffer H. Jonkman MF, et al. Among authors: pas hh. J Invest Dermatol. 1996 Nov;107(5):764-9. doi: 10.1111/1523-1747.ep12365805. J Invest Dermatol. 1996. PMID: 8875963 Free article.

7

Revertant mosaicism in epidermolysis bullosa caused by mitotic gene conversion.

Jonkman MF, Scheffer H, Stulp R, Pas HH, Nijenhuis M, Heeres K, Owaribe K, Pulkkinen L, Uitto J. Jonkman MF, et al. Among authors: pas hh. Cell. 1997 Feb 21;88(4):543-51. doi: 10.1016/s0092-8674(00)81894-2. Cell. 1997. PMID: 9038345 Free article.

8

Bullous pemphigoid and linear IgA dermatosis sera recognize a similar 120-kDa keratinocyte collagenous glycoprotein with antigenic cross-reactivity to BP180.

Pas HH, Kloosterhuis GJ, Heeres K, van der Meer JB, Jonkman MF. Pas HH, et al. J Invest Dermatol. 1997 Apr;108(4):423-9. doi: 10.1111/1523-1747.ep12289703. J Invest Dermatol. 1997. PMID: 9077469 Free article.

9

LAD-1 is absent in a subset of junctional epidermolysis bullosa patients.

Marinkovich MP, Tran HH, Rao SK, Giudice GJ, Balding S, Jonkman MF, Pas HH, McGuire JS, Herron GS, Bruckner-Tuderman L. Marinkovich MP, et al. Among authors: pas hh. J Invest Dermatol. 1997 Sep;109(3):356-9. doi: 10.1111/1523-1747.ep12336033. J Invest Dermatol. 1997. PMID: 9284104 Free article.

10

The use of skin substrates deficient in basement membrane molecules for the diagnosis of subepidermal autoimmune bullous disease.

Vodegel RM, Kiss M, Cjm De Jong M, Pas HH, Altmayer A, Molnar K, Husz S, Van Der Meer JB, Jonkman MF. Vodegel RM, et al. Among authors: pas hh. Eur J Dermatol. 1998 Mar;8(2):83-5. Eur J Dermatol. 1998. PMID: 9649654

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

169 results

Search Page

Filters